Bengaluru, Dec 6, 2024: Biocon Academy has recently organised a 5-day residential course aimed at pushing boundaries through innovative thinking and strategic collaborations in the field of drug discovery and development.
The 5th edition of the Medicinal Chemistry, Drug Discovery & Development India (MCADDI) 2024’ was organised in association with the American Chemical Society, Division of Medicinal Chemistry (ACSMEDI), Pharma Innovation Sourcing Centre LLC USA, International Union of Applied and Pure Chemistry (IUPAC), and ACS Publications.
Salavadi Easwaran, Academic Dean, Biocon Academy, said, “At Biocon Academy, our aim has always been to bridge the gap between industry and academia by delivering programs that equip aspiring professionals with industry-relevant skills. MCADDI 2024 provided a platform to participants to interact with leading experts in drug discovery and development, engage in insightful discussions on the latest advancements in medicinal chemistry and a lot more. This unique exposure helps them build a strong foundation for a successful career in the biotech sectors; positions them to meet the evolving demands and contribute meaningfully to global healthcare solutions.”
The program was attended by approximately 100 participants and led by 15 experts who conducted 32 impactful sessions on lead optimization, molecular modelling, in silico tools for medicinal chemistry, the role of heterocycles in drug design, and structure-based approaches to drug development. Innovative 3D lectures and interactive case studies were the limelight of the course, which gave hands-on experience and a deeper understanding of modern drug discovery to the participants.
Biocon Academy also announced a 100% placement success for Batch 6 of the Biocon Ramaiah Certificate Program in Quality Control Analytical, achieved in a record 2.5 hours.
The placement drive attracted top companies, including Biocon, Biocon Biologics, Syngene, RL Fine Chem, Dr. Reddy’s Laboratories, and Baxter. Students have secured roles in Quality Control, Analytical Research and Development, and Product Surveillance departments. About 80% of the batch members are female students.
Bindu Ajit, Program Dean, Biocon Academy, said, “I am delighted to see our students succeed—a testament to our commitment to quality and innovation. Our rigorous training, including functional visits, hands-on sessions and mock interviews, has broadened their learning horizons and prepared them for corporate life. By unlearning old concepts and embracing new knowledge, they have developed the professional skills and confidence needed in the industry. Congratulations to our students, and all the best for their future endeavours.”
Ramgopal Rao S, Senior Academic Manager and Coordinator for Biocon Ramaiah Certificate Program in Quality Control Analytical, Biocon Academy, said, “It is wonderful to see all the students from QCA Batch 6 secure placements on the first day in esteemed companies such as Baxter, Dr Reddy’s, Biocon, Biocon Biologics, Syngene, and RL Fine Chem, across both Quality Control and Analytical R&D departments. This achievement is a true testament to the skill development initiatives we at Biocon Academy are proudly committed to. As the course coordinator and trainer, it was incredibly rewarding to witness these young professionals land their first jobs on day one. Wishing them every success, and I am confident they will go on to be proud ambassadors of Biocon Academy.”
Biocon Academy’s tailored curriculum, developed in partnership with Ramaiah Institute, ensures students are equipped with a comprehensive foundation in Quality Control Analytical techniques and receives practical training.
x
